Spigelman Melvin K 4
4 · SYNERGY PHARMACEUTICALS, INC. · Filed Aug 16, 2018
Insider Transaction Report
Form 4
Spigelman Melvin K
Director
Transactions
- Tax Payment
Common Stock
2018-08-15−101,695→ 48,305 total - Exercise/Conversion
Common Stock
2018-08-15$1.20/sh+150,000$180,000→ 150,000 total - Exercise/Conversion
Stock Options
2018-08-15−150,000→ 474,364 totalExercise: $1.20Exp: 2018-08-21→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Represents the number of shares forfeited to the Company in payment of the exercise price of the stock options.
- [F2]Options became exercisable on 8/21/2009, 2010 and 2011.